F-box only protein 41
FBXO41 protein, partial (284-297), is a synthetic peptide fragment corresponding to amino acids 284 through 297 of the F-box only protein 41 (FBXO41). As a member of the F-box protein family, FBXO41 is recognized for its participation in protein-protein interactions and its role in ubiquitin-mediated proteolysis through the SCF (SKP1-CUL1-F-box protein) E3 ubiquitin ligase complex. The partial peptide sequence captures a defined region of the native protein, enabling targeted studies on sequence-specific interactions, post-translational modifications, and functional motifs within the FBXO41 structure. Researchers utilize such peptide fragments to dissect the molecular mechanisms underlying protein regulation, neuronal development, and cellular signaling pathways in which FBXO41 is implicated.
Protein interaction studies: The 284-297 peptide fragment serves as a valuable reagent for mapping protein-protein interaction domains within FBXO41. By employing this segment in pull-down assays, surface plasmon resonance, or co-immunoprecipitation experiments, scientists can identify and characterize binding partners specific to this region. Such applications are instrumental in elucidating the interaction networks that govern ubiquitin ligase activity, substrate recognition, and the broader regulatory roles of F-box proteins in cellular homeostasis.
Antibody generation and validation: The defined sequence of this partial peptide provides an immunogenic epitope for the generation of polyclonal or monoclonal antibodies targeting FBXO41. Researchers can use the peptide to immunize host animals or as an affinity ligand for antibody purification, ensuring high specificity toward the corresponding region of the native protein. These antibodies are essential tools for applications such as Western blotting, immunohistochemistry, and immunoprecipitation, thereby facilitating the study of FBXO41 expression, localization, and function in various biological samples.
Phosphorylation and post-translational modification analysis: The synthetic peptide encompassing amino acids 284-297 offers a controlled substrate for investigating post-translational modifications, including phosphorylation, acetylation, or ubiquitination. In vitro kinase assays or mass spectrometry analyses using this fragment can help pinpoint modification sites and their regulatory consequences. Understanding these modifications is critical for deciphering the molecular mechanisms by which FBXO41 activity and stability are modulated in response to cellular signals.
Structural and functional motif characterization: Researchers utilize the 284-297 region to probe structural motifs or functional domains within FBXO41. By synthesizing and analyzing this specific segment, it becomes possible to assess secondary structure propensity, binding affinities, or motif-mediated interactions with other biomolecules. Such studies contribute to a deeper understanding of how discrete regions of F-box proteins influence their biological activity, substrate specificity, and participation in multiprotein complexes.
Assay development and method validation: The defined peptide fragment is frequently employed as a standard or positive control in the development and optimization of biochemical assays targeting FBXO41 or related pathways. Its well-characterized sequence and reproducible properties facilitate quantitative analyses, method calibration, and validation of detection systems. This enables consistent and reliable measurement of protein interactions, modification events, or antibody performance in a variety of experimental settings, supporting robust data generation in both basic and applied research contexts.
4. C-Peptide replacement therapy and sensory nerve function in type 1 diabetic neuropathy
5. SERS spectrum of the peptide thymosin‐β4 obtained with Ag nanorod substrate
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More